Qinghong Yu Selected Research

2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamide

3/2022

Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinghong Yu Research Topics

Disease

4	Neoplasms (Cancer) 03/2022 - 03/2013
3	Rheumatoid Arthritis 01/2020 - 01/2019
2	Knee Osteoarthritis 05/2022 - 09/2020
2	Triple Negative Breast Neoplasms 03/2022 - 03/2022
2	Sepsis (Septicemia) 11/2020 - 11/2020
2	Septic Shock (Toxic Shock Syndrome) 11/2020 - 09/2020
2	Hypoalbuminemia 11/2020 - 09/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2020 - 03/2014
2	Arthritis (Polyarthritis) 01/2020 - 01/2019
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Overweight 05/2022
1	Breast Neoplasms (Breast Cancer) 03/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2022
1	Inflammation (Inflammations) 03/2022
1	Necrosis 03/2022
1	Ankylosing Spondylitis 03/2022
1	Critical Illness (Critically Ill) 02/2021
1	Osteoporosis 01/2021
1	Prurigo 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Experimental Arthritis 01/2021
1	Synovitis 09/2020
1	Pain (Aches) 09/2020
1	Bacteremia 09/2020
1	Hepatocellular Carcinoma (Hepatoma) 04/2020
1	Carcinogenesis 01/2019
1	Multiple Myeloma 06/2013

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 05/2022 - 03/2013
2	Phosphotransferases (Kinase)IBA 03/2022 - 03/2022
2	thiamine triphosphorate (TTP)IBA 11/2020 - 09/2020
2	Indicators and Reagents (Reagents)IBA 11/2020 - 11/2020
2	PhytochemicalsIBA 01/2020 - 01/2019
2	CytokinesIBA 01/2020 - 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 05/2022
1	ErbB Receptors (EGF Receptor)IBA 03/2022
1	naphthaIBA 03/2022
1	Estrogen ReceptorsIBA 03/2022
1	ethyl acetateIBA 03/2022
1	1-Butanol (n Butanol)IBA 03/2022
1	Nerve Growth Factor (NGF)IBA 03/2022
1	6- (2- aminocyclohexylamino)- 4- (5,6- dimethylpyridin- 2- ylamino)pyridazine- 3- carboxylic acid amideIBA 03/2022
1	4- (cyclopropylamino)- 2- ((4- (4- (ethylsulfonyl)piperazin- 1- yl)phenyl)amino)pyrimidine- 5- carboxamideIBA 03/2022
1	ER 27319IBA 03/2022
1	2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamideIBA 03/2022
1	fostamatinibIBA 03/2022
1	4- (3- (2H- 1,2,3- triazol- 2- yl)phenylamino)- 2- (2- aminocyclohexylamino)pyrimidine- 5- carboxamideIBA 03/2022
1	GSK143IBA 03/2022
1	Syk KinaseIBA 03/2022
1	C-Reactive ProteinIBA 03/2022
1	Capsules (Microcapsules)IBA 03/2022
1	DNA (Deoxyribonucleic Acid)IBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	IntegrinsIBA 03/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2022
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 03/2022
1	Vancomycin FDA LinkGeneric 02/2021
1	kirenolIBA 01/2021
1	baricitinibIBA 01/2021
1	DiterpenesIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 09/2020
1	Long Noncoding RNAIBA 04/2020
1	tanshinoneIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 12/2019
1	indole-3-carbinolIBA 01/2019
1	AcidsIBA 01/2019
1	MatrinesIBA 06/2013
1	Arsenic Trioxide (Trisenox)FDA Link 06/2013

Therapy/Procedure

2	Therapeutics 05/2022 - 03/2022
1	Continuous Renal Replacement Therapy 02/2021
1	Ovariectomy (Oophorectomy) 01/2021
1	Induction Chemotherapy 03/2014